Fundz

Nanochon raises $4M in a series seed prime round led by The University of Virginia Licensing and Ventures Group Seed Fund

PRIVATEMay 06, 2024

Amount Raised

$4 Million

Round Type

Seed

WashingtonInformation TechnologyBiotechnology

Investors

Cultivate (Md)Alumni Venture GroupMountain State CapitalThe University Of Virginia Licensing And Ventures Group Seed Fund

Description

Nanochon, a Washington, DC-based orthopedic device biotech company, has raised $4 million in a series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital. Nanochon intends to use the funds to initiate its first in human clinical trials in the US in 2024, deepen research and development efforts, expand the company’s patent profile, and grow its team.

Quick answer

Nanochon raised $4 Million in a Seed round, dated May 6, 2024. Investors: Cultivate (Md), Alumni Venture Group, Mountain State Capital and The University Of Virginia Licensing And Ventures Group Seed Fund. Nanochon is based in Washington, District Of Columbia, United States.

How much did Nanochon raise?
Nanochon raised $4 Million in a Seed round on May 6, 2024.
Who invested in Nanochon?
Cultivate (Md), Alumni Venture Group, Mountain State Capital and The University Of Virginia Licensing And Ventures Group Seed Fund are named as investors in this round.
What does Nanochon do?
Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions.
Where is Nanochon based and how big is it?
Nanochon is based in Washington, District Of Columbia, United States.
Who are the decision-makers at Nanochon?
Fundz holds 1 contact at Nanochon. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Nanochon that raised within 45 days of this round, from Fundz verified event records.

  • Ronovo Surgical raised $44M (Series B) on June 20, 2024.
  • Quantum Innovations raised $10M (Funding Round) on June 20, 2024.
  • Distil raised $3.1M (Funding Round) on June 20, 2024.
  • āshibio raised $40M (Series A) on June 20, 2024.
  • iOnctura BV raised $86M (Series B) on June 20, 2024.
  • Maxterial raised $8M (Series A) on June 20, 2024.

Who to call at Nanochon, and when

A new round usually means Nanochon is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nanochon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nanochon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nanochon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nanochon

Location

1317 Shepherd St NW

Washington, District Of Columbia, United States

About

Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions. Chondrograft™ is a minimally-invasive implant that allows for immediate weight-bearing and motion – meaning less time spent recovering. Nanochon has the potential to deliver more successful and longer-lasting recovery for patients than current standard of care. Our mission is to develop a new approach to treat cartilage replacement and repair so that the hundreds of thousands of young, active patients with joint damage can return to their lifestyles without having to undergo costly and invasive short-term fixes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nanochon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Nanochon's next move

See what Strategic adds

Nanochon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.